Initiate a rolling submission for tirzepatide in obesity
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 1 Nov 2022
- Due
- 31 Dec 2022
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Lilly plans to initiate a rolling submission in 2022”
What we found
Evidence strength A What the grades mean
The company confirmed in multiple SEC filings that it initiated a rolling submission for tirzepatide in obesity in the U.S. during 2022, meeting the stated deadline.
-
A ELI Lilly & Co 8-K filed 2023-02-02
“Additionally, the company initiated a rolling submission in the U.S. for tirzepatide in obesity” ✓ confirmed on the page
-
A ELI Lilly & Co 10-K filed 2023-02-22
“Initiated a rolling submission in the U.S. in 2022.” ✓ confirmed on the page
Market reaction: the shares moved -1.2% against the S&P 500 over the three sessions around the disclosure (1 Feb 2023 to 6 Feb 2023). What this measures
Checked 3 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Regulatory other
- Indicative materiality
- Medium rules
- Action
- Initiate
- Deliverable
- Rolling submission for tirzepatide
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
- Depends on
- Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you ELI Lilly & Co? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2022-LLY-004537 · Corrections policy